NYSE
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
The Hanover Insurance Group, Inc. provides property and casualty insurance products in the United States. The company operates through three segments: Commercial Lines, Personal Lines, and Other. The Other segment markets investment management services to institutions, pension funds, and other organizations.
Roles derived from SEC Form 4 filings.
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $4.8B | $5.2B | $5.5B | $6.0B | $6.2B | $6.6B |
| Gross profit | — | — | — | — | — | — |
| Operating income | $484.7M | $432.3M | $285.1M | $105.6M | $650.1M | $933.0M |
| Net income | $358.7M | $422.8M | $116.0M | $35.3M | $426.0M | $662.5M |
| Diluted EPS | $9.42 | $11.60 | $3.21 | $0.98 | $11.70 | $18.16 |
| Operating cash flow | $707.6M | $823.7M | $722.3M | $361.7M | $806.4M | $1.2B |
| Free cash flow | $692.7M | $815.7M | $704.5M | $349.8M | $796.2M | $1.2B |
| Gross margin | — | — | — | — | — | — |
| Operating margin | 10.0% | 8.3% | 5.2% | 1.8% | 10.4% | 14.1% |
| Net margin | 7.4% | 8.1% | 2.1% | 0.6% | 6.8% | 10.0% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.5B | $1.6B | $1.6B | $1.6B | $1.7B | $1.7B | $1.7B | $1.7B |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $95.4M | $150.6M | $254.4M | $186.4M | $209.9M | $247.7M | $289.0M | $250.2M |
| Net income | $40.5M | $102.1M | $167.9M | $128.2M | $157.1M | $178.7M | $198.5M | $186.8M |
| Diluted EPS | $1.12 | $2.80 | $4.60 | $3.50 | $4.30 | $4.90 | $5.46 | $5.20 |
| Operating cash flow | $139.5M | $394.7M | $213.5M | $38.9M | $206.6M | $554.4M | $378.2M | $118.8M |
| Free cash flow | $137.3M | $392.3M | $210.5M | $37.1M | $204.9M | $551.4M | $377.0M | $115.3M |
| Gross margin | — | — | — | — | — | — | — | — |
| Operating margin | 6.2% | 9.6% | 16.1% | 11.6% | 12.7% | 14.9% | 17.3% | 14.7% |
| Net margin | 2.6% | 6.5% | 10.6% | 8.0% | 9.5% | 10.7% | 11.9% | 11.0% |
Consensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-06-26 | LANE KATHY S | Award | 4 | $0.00 | $0.00 | filing |
| 2026-06-26 | Egan Cynthia | Award | 4 | $0.00 | $0.00 | filing |
| 2026-06-26 | Carlin Jane D | Award | 4 | $0.00 | $0.00 | filing |
| 2026-06-26 | Bunting Theodore H JR | Award | 4 | $0.00 | $0.00 | filing |
| 2026-06-26 | Donnell William E. | Award | 4 | $0.00 | $0.00 | filing |
| 2026-06-26 | Unknown | Award | 4 | $0.00 | $0.00 | filing |
| 2026-06-26 | Aristeguieta Francisco | Award | 4 | $0.00 | $0.00 | filing |
| 2026-06-26 | Condrin J Paul | Award | 4 | $0.00 | $0.00 | filing |
| 2026-06-26 | RAMRATH JOSEPH R | Award | 4 | $0.00 | $0.00 | filing |
| 2026-06-26 | Ward Elizabeth A | Award | 4 | $0.00 | $0.00 | filing |
| 2026-06-26 | Salvatore Bryan J· Executive Vice President | Award | 25 | $0.00 | $0.00 | filing |
| 2026-06-26 | Roche John C· President and CEO | Award | 122 | $0.00 | $0.00 | filing |
| 2026-06-26 | Norton-Gatto Patricia A.· SVP & Princpl. Accntg. Officer | Award | 6 | $0.00 | $0.00 | filing |
| 2026-06-26 | LOVELY DAVID JOHN· Executive Vice President | Award | 11 | $0.00 | $0.00 | filing |
| 2026-06-26 | Lee Willard T· Executive Vice President | Award | 11 | $0.00 | $0.00 | filing |
| 2026-06-26 | LAVEY RICHARD W· Executive Vice President | Award | 28 | $0.00 | $0.00 | filing |
| 2026-06-26 | Kerrigan Dennis Francis· Executive Vice President | Award | 15 | $0.00 | $0.00 | filing |
| 2026-06-26 | FARBER JEFFREY M· Executive Vice President | Award | 43 | $0.00 | $0.00 | filing |
| 2026-06-03 | Salvatore Bryan J· Executive Vice President | Sale | 16,394 | $185.76 | $3.0M | filing |
| 2026-06-03 | Salvatore Bryan J· Executive Vice President | Option exercise | 16,394 | $104.11 | $1.7M | filing |
| 2026-05-21 | Aristeguieta Francisco | Sale | 1,000 | $195.37 | $195,370.00 | filing |
| 2026-05-20 | Kerrigan Dennis Francis· Executive Vice President | Sale | 6,262 | $192.99 | $1.2M | filing |
| 2026-05-20 | Roche John C· President and CEO | Sale | 5,145 | $194.05 | $998,387.25 | filing |
| 2026-05-20 | Kerrigan Dennis Francis· Executive Vice President | Option exercise | 6,262 | $115.35 | $722,321.70 | filing |
| 2026-05-20 | Roche John C· President and CEO | Sale | 3,152 | $193.21 | $608,997.92 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.